{"id":"W4379279894","doi":"10.1017/cjn.2023.149","title":"P.045 Safety profile overview of Efgartigimod Clinical Trials in participants with diverse Diverse IgG-Mediated Autoimmune Diseases","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Systems, Applications & Products in Data Processing (Canada)","funders":"","keywords":"Dosing; Placebo; Adverse effect; Medicine; Discontinuation; Myasthenia gravis; Pemphigus; Clinical trial; Internal medicine; Antibody; Autoantibody; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009928747,0.0007567566,0.001123479,0.001349503,0.0003718295,0.001582437,0.000642627,0.001190413,0.008468018],"category_scores_gemma":[0.006908803,0.0003015935,0.002262469,0.002094178,0.0003616938,0.0007104832,0.000416397,0.001352815,0.001589753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008118551,"about_ca_system_score_gemma":0.001346659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004646726,"about_ca_topic_score_gemma":0.001259845,"domain_scores_codex":[0.9953431,0.002615175,0.0007192212,0.0003241212,0.0008407506,0.0001577201],"domain_scores_gemma":[0.9927877,0.003033313,0.002266272,0.0002168191,0.001330521,0.0003653999],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05758748,0.0008795037,0.01377923,0.02294011,0.008395073,0.0004393857,0.0002315331,0.002013151,0.01683889,0.002110647,0.03294221,0.8418428],"study_design_scores_gemma":[0.1080033,0.1364749,0.1572875,0.01989788,0.02372087,0.005318772,0.0005352311,0.005017507,0.01619352,0.008275505,0.5190229,0.0002521143],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1711213,0.6543515,0.01573297,0.01128402,0.001348524,0.01090474,0.02473946,0.0008911208,0.1096263],"genre_scores_gemma":[0.6797517,0.238597,0.02064287,0.0122855,0.003229521,0.009502409,0.02019381,0.0002669363,0.01553028],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.009928747,"threshold_uncertainty_score":0.05250889,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1971067775684784,"score_gpt":0.3968801998193601,"score_spread":0.1997734222508817,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}